Morley James F, Cheng Gang, Dubroff Jacob G, Wood Stephanie, Wilkinson Jayne R, Duda John E
Parkinson's Disease Research Education Clinical and Education Center Corporal Michael J. Crescenz VA Medical Center Philadelphia Pennsylvania USA.
Department of Neurology University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA.
Mov Disord Clin Pract. 2016 Nov 28;4(4):603-606. doi: 10.1002/mdc3.12458. eCollection 2017 Jul-Aug.
Drug-induced parkinsonism (DIP) is common, and the motor symptoms can be indistinguishable from Parkinson's disease (PD). When symptoms persist after drug withdrawal, this may represent "unmasking" of underlying PD. We previously reported that hyposmia, a common nonmotor feature of PD, was associated with persistent DIP. Here, we report on a series of 33 consecutive patients who underwent dopamine transporter imaging to evaluate DIP. We examined the clinical correlates of underlying dopaminergic denervation by comparing subjects with normal and abnormal scans. Imaging was abnormal in 7 of 33 (21%) cases. Motor features were similar in patients with normal and abnormal scans. Olfactory testing was available for 30 subjects and was concordant with imaging in 27 of 30 (odds ratio = 63; 95% confidence interval: 4.8-820; = 0.002). Olfactory testing may be a simple screen to help identify DIP patients with underlying dopaminergic denervation, consistent with unmasking of incipient PD.
药物性帕金森综合征(DIP)很常见,其运动症状可能与帕金森病(PD)难以区分。当停药后症状仍持续存在时,这可能代表潜在PD的“暴露”。我们之前报道过,嗅觉减退作为PD常见的非运动特征,与持续性DIP有关。在此,我们报告了连续33例接受多巴胺转运体成像以评估DIP的患者。我们通过比较扫描正常和异常的受试者,研究了潜在多巴胺能去神经支配的临床相关性。33例中有7例(21%)成像异常。扫描正常和异常的患者运动特征相似。30名受试者可进行嗅觉测试,其中27例嗅觉测试结果与成像结果一致(优势比=63;95%置信区间:4.8 - 820;P = 0.002)。嗅觉测试可能是一种简单的筛查方法,有助于识别存在潜在多巴胺能去神经支配的DIP患者,这与早期PD的暴露一致。